Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 29
2017 58
2018 71
2019 83
2020 67
2021 18
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Results by year
Filters applied: . Clear all
Page 1
Opioid Use Disorder and COVID-19: Crashing of the Crises.
Khatri UG, Perrone J. Khatri UG, et al. J Addict Med. 2020 Jul/Aug;14(4):e6-e7. doi: 10.1097/ADM.0000000000000684. J Addict Med. 2020. PMID: 32404651 Free PMC article.
: The COVID19 crisis has created many additional challenges for patients with opioid use disorder, including those seeking treatment with medications for OUD. Some of these challenges include closure of substance use treatment clinics, focus of emergency departments …
: The COVID19 crisis has created many additional challenges for patients with opioid use disorder, including those seeking treatment
Patient-centered Care to Address Barriers for Pregnant Women with Opioid Dependence.
Sutter MB, Gopman S, Leeman L. Sutter MB, et al. Obstet Gynecol Clin North Am. 2017 Mar;44(1):95-107. doi: 10.1016/j.ogc.2016.11.004. Obstet Gynecol Clin North Am. 2017. PMID: 28160896 Review.
Pregnant women affected by substance use often encounter barriers to treatment, including housing insecurity, poverty, mental health issues, social stigma, and access to health care. ...Collaboration between providers of maternity care, substance abuse treatment
Pregnant women affected by substance use often encounter barriers to treatment, including housing insecurity, poverty, mental …
Innovation During COVID-19: Improving Addiction Treatment Access.
Samuels EA, Clark SA, Wunsch C, Jordison Keeler LA, Reddy N, Vanjani R, Wightman RS. Samuels EA, et al. J Addict Med. 2020 Jul/Aug;14(4):e8-e9. doi: 10.1097/ADM.0000000000000685. J Addict Med. 2020. PMID: 32404652 Free PMC article.
: During the COVID-19 pandemic, many addiction treatment and harm reduction organizations have had to reduce their hours and services for people with substance use disorders, placing these individuals at increased risk of death. ...In this new regulatory environment, we es …
: During the COVID-19 pandemic, many addiction treatment and harm reduction organizations have had to reduce their hours and services …
How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment?
Huskamp HA, Busch AB, Souza J, Uscher-Pines L, Rose S, Wilcock A, Landon BE, Mehrotra A. Huskamp HA, et al. Health Aff (Millwood). 2018 Dec;37(12):1940-1947. doi: 10.1377/hlthaff.2018.05134. Health Aff (Millwood). 2018. PMID: 30633671 Free PMC article.
Only a small proportion of people with a substance use disorder (SUD) receive treatment. The shortage of SUD treatment providers, particularly in rural areas, is an important driver of this treatment gap. Telemedicine could be a means of expanding access to …
Only a small proportion of people with a substance use disorder (SUD) receive treatment. The shortage of SUD treatment provide …
Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs.
Parashar S, Collins AB, Montaner JS, Hogg RS, Milloy MJ. Parashar S, et al. Curr Opin HIV AIDS. 2016 Sep;11(5):507-513. doi: 10.1097/COH.0000000000000297. Curr Opin HIV AIDS. 2016. PMID: 27254749 Free PMC article. Review.
Elevated mortality levels in this population are driven by social-structural barriers to ART access and adherence, particularly criminalization and stigmatization of drug use. ...SUMMARY: The life-saving benefits of ART can be realized among HIV-positive PWID when it is pa …
Elevated mortality levels in this population are driven by social-structural barriers to ART access and adherence, particularly crimi …
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Wakeman SE, et al. JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622. JAMA Netw Open. 2020. PMID: 32022884 Free article.
IMPORTANCE: Although clinical trials demonstrate the superior effectiveness of medication for opioid use disorder (MOUD) compared with nonpharmacologic treatment, national data on the comparative effectiveness of real-world treatment pathways are lacking. ...For OUD …
IMPORTANCE: Although clinical trials demonstrate the superior effectiveness of medication for opioid use disorder (MOUD) compared with nonph …
Stigma at every turn: Health services experiences among people who inject drugs.
Paquette CE, Syvertsen JL, Pollini RA. Paquette CE, et al. Int J Drug Policy. 2018 Jul;57:104-110. doi: 10.1016/j.drugpo.2018.04.004. Epub 2018 Apr 30. Int J Drug Policy. 2018. PMID: 29715589 Free PMC article.
Participants described feeling similarly stigmatized in their meso-level interactions with first responders and hospital staff, and associated this stigmatization with delayed and substandard medical care for overdoses and injection-related infections. Drug treatment was a …
Participants described feeling similarly stigmatized in their meso-level interactions with first responders and hospital staff, and associat …
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD. Velasquez M, et al. Addict Sci Clin Pract. 2019 Oct 1;14(1):37. doi: 10.1186/s13722-019-0166-0. Addict Sci Clin Pract. 2019. PMID: 31570100 Free PMC article.
Purposeful sampling recruited persons leaving jail on XR-NTX (n = 11), no active medication treatment (n = 9), methadone (n = 9), and buprenorphine (n = 4). Emergent themes were: (1) general satisfaction with XR-NTX's long-acting antagonist effects and control of cravings; …
Purposeful sampling recruited persons leaving jail on XR-NTX (n = 11), no active medication treatment (n = 9), methadone (n = 9), and …
Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.
Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Mojtabai R, et al. Health Aff (Millwood). 2019 Jan;38(1):14-23. doi: 10.1377/hlthaff.2018.05162. Health Aff (Millwood). 2019. PMID: 30615514 Free PMC article.
Medication treatment (MT) is one of the few evidence-based strategies proposed to combat the current opioid epidemic. We examined national trends and correlates of offering MT in substance use treatment facilities in the United States. According to data from nationa …
Medication treatment (MT) is one of the few evidence-based strategies proposed to combat the current opioid epidemic. We examined nat …
269 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page